Table 1. . Summary of patient characteristics for specimens used in the present study.
Patient characteristics | rs12459419 genotype | |||||||
---|---|---|---|---|---|---|---|---|
CC | CT | TT | Total | |||||
(n = 5)† | (n = 5) | (n = 4)† | (N = 14) | |||||
n | % | n | % | n | % | N | % | |
Sex | ||||||||
– Female | 2 | 50.0 | 2 | 40.0 | 3 | 60.0 | 7 | 50.0 |
Age | ||||||||
– Years, median (range) | 11.4 (8.7–16.0) |
13.6 (11.5–17.3) |
2.0 (1.7–16.2) |
11.8 (1.6–17.3) |
||||
Race | ||||||||
– White | 4 | 100.0 | 4 | 80.0 | 4 | 66.7 | 12 | 92.3 |
– Unknown | 0 | 0.0 | 1 | 20.0 | 1 | 16.7 | 2 | 15.4 |
Risk group | ||||||||
– High | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
– Standard | 0 | 0.0 | 2 | 40.0 | 3 | 60.0 | 5 | 35.7 |
– Low | 4 | 100.0 | 3 | 60.0 | 2 | 40.0 | 9 | 64.3 |
Clinical features | ||||||||
– BM blast (%), median (range) | 61 (36–90) |
65† (49–80) |
81 (25–90) |
80 (25–90) |
One patient sample with unavailable demographic data.
BM: Bone marrow; CC: Homozygous dominant; CT: Heterozygous; TT: Homozygous recessive.